诺比林
内科学
内分泌学
氮氧化物4
氧化应激
肾
血管紧张素II
医学
化学
NADPH氧化酶
血压
抗氧化剂
生物化学
类黄酮
作者
Metee Iampanichakul,Anuson Poasakate,Prapassorn Potue,Siwayu Rattanakanokchai,Putcharawipa Maneesai,Parichat Prachaney,Wannapa Settheetham‐Ishida,Poungrat Pakdeechote
标识
DOI:10.1038/s41598-022-13513-6
摘要
This study investigated the effects of nobiletin on cardiorenal changes and the underlying mechanisms involved in two-kidney, one-clip (2K-1C) hypertension. 2K-1C rats were treated with nobiletin (15 or 30 mg/kg/day) or losartan (10 mg/kg/day) for 4 weeks ( n = 8/group). Nobiletin (30 mg/kg) reduced high levels of blood pressure and circulating angiotensin II and angiotensin-converting enzyme activity in 2K-1C rats. Left ventricular (LV) dysfunction and remodelling in 2K-1C rats were alleviated in the nobiletin-treated group ( P < 0.05). Nobiletin reduced the upregulation of Ang II type I receptor (AT 1 R)/JAK (Janus kinase)/STAT (signal transducer and activator of transcription) protein expression in cardiac tissue of 2K-1C rats ( P < 0.05). The reduction in kidney function, and accumulation of renal fibrosis in 2K-1C rats were alleviated by nobiletin ( P < 0.05). Overexpression of AT 1 R and NADPH oxidase 4 (Nox4) protein in nonclipped kidney tissue was suppressed in the nobiletin-treated group ( P < 0.05). The elevations in oxidative stress parameters and the reductions in antioxidant enzymes were attenuated in 2K-1C rats treated with nobiletin ( P < 0.05). In summary, nobiletin had renin-angiotensin system inhibitory and antioxidant effects and attenuated LV dysfunction and remodelling via restoration of the AT 1 R/JAK/STAT pathway. Nobiletin also resolved renal damage that was related to modulation of the AT 1 R/Nox4 cascade in 2K-1C hypertension.
科研通智能强力驱动
Strongly Powered by AbleSci AI